FDA Gives Firms Hawking H1N1 Remedies Tighter Deadline To Comply

FDA's threats of near-immediate action against firms selling products with claims of treating the 2009-H1N1 flu virus are the sign of a fleet-footed and serious agency, says a food and drug attorney